Informations:
Erreur:
ID
23029
Description
The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthritis. A Pilot Study.; ODM derived from: https://clinicaltrials.gov/show/NCT01270087
Lien
https://clinicaltrials.gov/show/NCT01270087
Mots-clés
Versions (1)
- 20/06/2017 20/06/2017 -
Téléchargé le
20 juin 2017
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Rheumatoid Arthritis NCT01270087
Eligibility Rheumatoid Arthritis NCT01270087
- StudyEvent: Eligibility
Similar models
Eligibility Rheumatoid Arthritis NCT01270087
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Rheumatoid Arthritis
Item
clinical diagnosis of rheumatoid arthritis
boolean
C0003873 (UMLS CUI [1])
Rheumatoid Arthritis Criteria Fulfill
Item
fulfillment of the american college of rheumatology 1987 criteria for rheumatoid arthritis
boolean
C0003873 (UMLS CUI [1,1])
C0243161 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
C0243161 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,3])
Disease-Modifying Antirheumatic Drugs Quantity | Persistent Disease
Item
active disease despite treatment with at least one disease modifying anti-rheumatic drug
boolean
C0242708 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C2983415 (UMLS CUI [2])
C1265611 (UMLS CUI [1,2])
C2983415 (UMLS CUI [2])
Indication adalimumab
Item
treatment with adalimumab indicated according to the the patient's rheumatologist
boolean
C3146298 (UMLS CUI [1,1])
C1122087 (UMLS CUI [1,2])
C1122087 (UMLS CUI [1,2])
Swollen joint Quantity Disease activity score using 28 joint count
Item
at least six swollen joints in 28-joint index
boolean
C0152031 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C2711347 (UMLS CUI [1,3])
C1265611 (UMLS CUI [1,2])
C2711347 (UMLS CUI [1,3])
C-reactive protein measurement
Item
crp > 8 mg / l within the last three months
boolean
C0201657 (UMLS CUI [1])
Anti-tumor necrosis factor alpha drug
Item
treatment with anti-tnf drugs in the last three months
boolean
C1562242 (UMLS CUI [1])
Adrenal Cortex Hormones Intravenous
Item
treatment with intravenous corticosteroids within fourteen days
boolean
C0001617 (UMLS CUI [1,1])
C1522726 (UMLS CUI [1,2])
C1522726 (UMLS CUI [1,2])
Adrenal Cortex Hormones Oral High dose | Prednisolone U/day equivalent | Adrenal Cortex Hormones Oral High dose Treatment completed
Item
ongoing treatment with oral high-dose corticosteroids (equivalent to ≥ 20 mg of prednisolon daily) or completed such treatment less than fifteen days before inclusion
boolean
C0001617 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0444956 (UMLS CUI [1,3])
C0032950 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
C3242703 (UMLS CUI [2,3])
C0001617 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
C0444956 (UMLS CUI [3,3])
C0580352 (UMLS CUI [3,4])
C1527415 (UMLS CUI [1,2])
C0444956 (UMLS CUI [1,3])
C0032950 (UMLS CUI [2,1])
C0456683 (UMLS CUI [2,2])
C3242703 (UMLS CUI [2,3])
C0001617 (UMLS CUI [3,1])
C1527415 (UMLS CUI [3,2])
C0444956 (UMLS CUI [3,3])
C0580352 (UMLS CUI [3,4])
Blood Coagulation Disorder Severe
Item
severe bleeding disorder
boolean
C0005779 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])
Leg Ulcer Extensive | Leg Ulcer refractory
Item
extensive or refractory leg ulcers
boolean
C0023223 (UMLS CUI [1,1])
C0205231 (UMLS CUI [1,2])
C0023223 (UMLS CUI [2,1])
C0205269 (UMLS CUI [2,2])
C0205231 (UMLS CUI [1,2])
C0023223 (UMLS CUI [2,1])
C0205269 (UMLS CUI [2,2])
Peripheral Vascular Disease Severe
Item
severe peripheral vascular disease
boolean
C0085096 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,2])